Nalpha-fmoc-ndelta-trityl-l-ornithine is a doubly protected ornithine derivative used to install branching or reactive side-chain functionalities. The trityl group enables controlled deprotection for downstream modifications. Researchers use it in cyclic peptide synthesis and structure-guided design. Its versatility supports complex peptide assembly.
CAT No: R2132
CAS No:1998701-26-0
Synonyms/Alias:1998701-26-0;Fmoc-Orn(Trt)-OH;Nalpha-fmoc-ndelta-trityl-l-ornithine;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-(tritylamino)pentanoic acid;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tritylamino)pentanoic acid;DTXSID501153417;MFCD30478737;N-alpha-Fmoc-N-delta-trityl-L-Ornithine;AS-83863;E70922;N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N5-(triphenylmethyl)-L-ornithine;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-5-[(triphenylmethyl)amino]pentanoic acid;(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-[(triphenylmethyl)amino]pentanoic acid;
1. Cationic cell-penetrating peptides are potent furin inhibitors
2. Myotropic activity of allatostatins in tenebrionid beetles
3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More